150 related articles for article (PubMed ID: 20232407)
1. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients.
Kosovac K; Brenmoehl J; Holler E; Falk W; Schoelmerich J; Hausmann M; Rogler G
Inflamm Bowel Dis; 2010 Aug; 16(8):1311-21. PubMed ID: 20232407
[TBL] [Abstract][Full Text] [Related]
2. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
3. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
[TBL] [Abstract][Full Text] [Related]
4. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
5. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
6. MIP-3α expression in macrophages is NOD dependent.
Hausmann M; Zeitler C; Weber A; Krebs M; Kellermeier S; Rosenstiel P; de Vallière C; Kosovac K; Fried M; Holler E; Rogler G
Digestion; 2012; 85(3):192-201. PubMed ID: 22286692
[TBL] [Abstract][Full Text] [Related]
7. The NOD2-RICK complex signals from the plasma membrane.
Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
[TBL] [Abstract][Full Text] [Related]
8. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.
Beynon V; Cotofana S; Brand S; Lohse P; Mair A; Wagner S; Mussack T; Ochsenkühn T; Folwaczny M; Folwaczny C; Glas J; Török HP
Inflamm Bowel Dis; 2008 Aug; 14(8):1033-40. PubMed ID: 18383179
[TBL] [Abstract][Full Text] [Related]
9. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
10. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition.
Barnich N; Aguirre JE; Reinecker HC; Xavier R; Podolsky DK
J Cell Biol; 2005 Jul; 170(1):21-6. PubMed ID: 15998797
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
Gutiérrez A; Scharl M; Sempere L; Holler E; Zapater P; Almenta I; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
Gut; 2014 Feb; 63(2):272-80. PubMed ID: 23376290
[TBL] [Abstract][Full Text] [Related]
12. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion.
Rosenstiel P; Sina C; End C; Renner M; Lyer S; Till A; Hellmig S; Nikolaus S; Fölsch UR; Helmke B; Autschbach F; Schirmacher P; Kioschis P; Hafner M; Poustka A; Mollenhauer J; Schreiber S
J Immunol; 2007 Jun; 178(12):8203-11. PubMed ID: 17548659
[TBL] [Abstract][Full Text] [Related]
13. [Intestinal flora and Crohn's disease].
Desreumaux P; Colombel JF
Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.
Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M
Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
[TBL] [Abstract][Full Text] [Related]
18. Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.
Seidelin JB; Broom OJ; Olsen J; Nielsen OH
PLoS One; 2009 Nov; 4(11):e7794. PubMed ID: 19907652
[TBL] [Abstract][Full Text] [Related]
19. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
20. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
